Trial intelligence / Profile preview

App Supporting Psoriasis Patients to Improve Adherence

NCT02858713Phase 4Completed

Sponsor
University Hospital Odense
Start
Jan 2017
Primary completion
Apr 2017
Countries
1
01

Overview

Phase 4, randomised, single-blind trial in psoriasis (2 arms), sponsored by University Hospital Odense. Primary endpoint: Percentage of Adherent Participants at 4 weeks. Started Jan 2017; status: completed.

02

Conditions

psoriasis

Beyond the preview

Go deeper on NCT02858713.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02858713.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call